drugset / Trial / NCT00474136
Study to Compare the Pharmacokinetics of IV Diclofenac Sodium (2 Doses)Versus Oral Diclofenac Potassium
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to assess the pharmacokinetic parameters of intravenous diclofenac sodium (DIC075V) 18.75 mg and 37.5 mg following single- and multiple-dose administration, as compared to oral diclofenac potassium (Cataflam® 50 mg), the approved reference product.
Timeline
- Start
- 2007-03
- Primary completion
- 2007-05
- Completion
- 2007-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Diclofenac | Other / unclassified | 18.75 mg | Intravenous |
| Comparator | Diclofenac | Other / unclassified | 37.5 mg | Intravenous |
| Comparator | Diclofenac | Other / unclassified | 50 mg | Oral |
Indications
No indication recorded.